Tagged With: 9/28/18

Welcome to the latest edition of NORML’s Weekly Legislative Roundup! This week, the U.S. Drug Enforcement Administration placed CBD medication Epidiolex in Schedule V, the least restrictive category of the Controlled Substances Act. The move does not apply to CBD itself or other non-FDA-approved extracts containing it. U.S. Customs and Border Protection released an official … Continue reading »